KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $176.0 million.

  • Resmed's Current Deferred Revenue rose 1248.63% to $176.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $176.0 million, marking a year-over-year increase of 1248.63%. This contributed to the annual value of $166.0 million for FY2025, which is 883.36% up from last year.
  • Per Resmed's latest filing, its Current Deferred Revenue stood at $176.0 million for Q4 2025, which was up 1248.63% from $167.8 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Current Deferred Revenue ranged from a high of $176.0 million in Q4 2025 and a low of $105.3 million during Q1 2021
  • For the 5-year period, Resmed's Current Deferred Revenue averaged around $138.2 million, with its median value being $143.9 million (2023).
  • In the last 5 years, Resmed's Current Deferred Revenue tumbled by 385.06% in 2022 and then skyrocketed by 3560.52% in 2023.
  • Quarter analysis of 5 years shows Resmed's Current Deferred Revenue stood at $111.6 million in 2021, then grew by 19.94% to $133.9 million in 2022, then grew by 11.19% to $148.9 million in 2023, then rose by 5.11% to $156.5 million in 2024, then increased by 12.49% to $176.0 million in 2025.
  • Its last three reported values are $176.0 million in Q4 2025, $167.8 million for Q3 2025, and $166.0 million during Q2 2025.